US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Q32 Bio Inc.

1.64

+0.08005.13%

Post-market: 1.730.0900+5.49%19:35 EDT

Volume:176.75K

Turnover:287.76K

Market Cap:20.00M

PE:-0.25

High:1.70

Open:1.53

Low:1.53

Close:1.56

Loading ...

Overview Company News Filings

Q32 Bio Inc : Bmo Cuts to Market Perform From Outperform; Cuts Target Price to $3 From $22

THOMSON REUTERS

Q32 Bio Unveils Restructuring to Focus on Alopecia Areata Treatment; Shares Fall

MT Newswires Live

Q32 Bio Cut to Market Perform From Outperform by BMO Capital

Piper Sandler Downgrades Q32 Bio to Neutral From Overweight, Adjusts Price Target to $4 From $20

MT Newswires Live

Q32 Bio Cut to Neutral From Overweight by Piper Sandler

Q32 Bio downgraded to Neutral from Overweight at Piper Sandler

BRIEF-Q32 Bio Inc Restructuring Plan Includes Reduction In Force, Which Co Expects To Substantially Complete By End Of Q2 Of 2025

BRIEF-Q32 Bio Inc To Discontinue Renal Basket Trial For Adx-097 To Conserve Resources

Q32 Bio Inc: Expects to Incur Severance and Severance-Related Charges of About $1.1 Mln

THOMSON REUTERS

Q32 Bio Inc: Restructuring Plan Includes Reduction in Force, Which Co Expects to Substantially Complete by End of Q2 of 2025

THOMSON REUTERS

Q32 Bio Inc: Cash Runway Expected to Extend to 2H'26

THOMSON REUTERS

Q32 Bio Inc: Initiating Open-Label Extension From Signal-Aa Part a in 1H'25

THOMSON REUTERS

Q32 Bio Inc: Signal-Aa Part B Remains on Track for Initiation of Dosing in 1H'25, With Topline Data Expected in 1H'26

THOMSON REUTERS

Q32 Bio Inc: to Discontinue Renal Basket Trial for Adx-097 to Conserve Resources

THOMSON REUTERS

Q32 Bio Inc: Evaluate Strategic Options for Its Tissue-Targeted Complement Inhibitor Platform

THOMSON REUTERS

BUZZ-Guggenheim downgrades Q32 Bio to 'neutral' as dermatitis drug fails in part of study

Q32 Bio Inc Shares Hit Record Low After Guggenheim Downgrades Stock, Last Down 21.2%

THOMSON REUTERS

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday

Q32 Bio Cut to Neutral From Buy by Guggenheim

Q32 Bio Inc : Bmo Cuts Target Price to $22 From $64

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/QTTB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QTTB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QTTB\",,,,,undefined,":{"symbol":"QTTB","market":"US","secType":"STK","nameCN":"Q32 Bio Inc.","latestPrice":1.64,"timestamp":1746216000000,"preClose":1.56,"halted":0,"volume":176749,"hourTrading":{"tag":"盘后","latestPrice":1.73,"preClose":1.64,"latestTime":"19:35 EDT","volume":2165,"amount":3694.32,"timestamp":1746228922245},"delay":0,"floatShares":4728923,"shares":12197615,"eps":-6.578484,"marketStatus":"Market Closed","change":0.08,"latestTime":"05-02 16:00:00 EDT","open":1.53,"high":1.7,"low":1.53,"amount":287757.5880922,"amplitude":0.108974,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.578484,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1522209600000,"exchange":"NASDAQ","adjPreClose":1.56,"preHourTrading":{"tag":"盘前","latestPrice":1.53,"preClose":1.56,"latestTime":"09:29 EDT","volume":3578,"amount":5517.719672,"timestamp":1746192598425},"postHourTrading":{"tag":"盘后","latestPrice":1.73,"preClose":1.64,"latestTime":"19:35 EDT","volume":2165,"amount":3694.32,"timestamp":1746228922245},"volumeRatio":0.437979,"impliedVol":0.7108,"impliedVolPercentile":0.2671},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QTTB\",,,,,undefined,":{"symbol":"QTTB","floatShares":4728923,"roa":"-59.28%","roe":"--","lyrEps":-5.12108,"volumeRatio":0.437979,"shares":12197615,"dividePrice":0,"high":1.7,"amplitude":0.108974,"preClose":1.56,"low":1.53,"week52Low":1.38,"pbRate":"3.52","psRate":"-1.36","week52High":53.79,"institutionHeld":0,"latestPrice":1.64,"eps":-6.578484,"divideRate":0,"volume":176749,"delay":0,"ttmEps":-6.578484,"open":1.53,"prevYearClose":3.44,"prevWeekClose":1.87,"prevMonthClose":1.6,"prevQuarterClose":1.65,"fiveDayClose":1.87,"twentyDayClose":1.6,"sixtyDayClose":3.36},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QTTB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510206723","title":"Q32 Bio Inc : Bmo Cuts to Market Perform From Outperform; Cuts Target Price to $3 From $22","url":"https://stock-news.laohu8.com/highlight/detail?id=2510206723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510206723?lang=en_us&edition=fundamental","pubTime":"2025-02-12 19:44","pubTimestamp":1739360661,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P31BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"gpt_icon":0},{"id":"2510330894","title":"Q32 Bio Unveils Restructuring to Focus on Alopecia Areata Treatment; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2510330894","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510330894?lang=en_us&edition=fundamental","pubTime":"2025-02-12 01:41","pubTimestamp":1739295672,"startTime":"0","endTime":"0","summary":"Q32 Bio  shares were down Tuesday after the company said late Monday it was implementing a corporate restructuring to focus on advancing the bempikibart clinical development program for the treatment of alopecia areata.The company is halting its phase 2 renal basket trial of ADX-097 and exploring strategic options for its tissue-targeted complement inhibitor platform, Q32 Bio said, adding that the restructuring, which includes workforce reductions, is projected to extend its cash runway until H2 of 2026.Following positive results from the SIGNAL-AA part A trial, which showed Severity of Alopecia Tool score improvements and sustained response through week 55, the company said it plans to launch an open-label extension in H1 2025. The company also said it will begin dosing for SIGNAL-AA part B in H1, evaluating about 20 patients with severe AA over 36 weeks, with topline results expected in H1 of 2026.Separately, Piper Sandler downgraded the company's stock to neutral from overweight, an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QTTB","BK4139"],"gpt_icon":0},{"id":"2510844263","title":"Q32 Bio Cut to Market Perform From Outperform by BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2510844263","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510844263?lang=en_us&edition=fundamental","pubTime":"2025-02-11 22:10","pubTimestamp":1739283000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QTTB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2025 09:10 ET (14:10 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMO","QTTB"],"gpt_icon":0},{"id":"2510138930","title":"Piper Sandler Downgrades Q32 Bio to Neutral From Overweight, Adjusts Price Target to $4 From $20","url":"https://stock-news.laohu8.com/highlight/detail?id=2510138930","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510138930?lang=en_us&edition=fundamental","pubTime":"2025-02-11 21:29","pubTimestamp":1739280599,"startTime":"0","endTime":"0","summary":"Q32 Bio (QTTB) has an average rating of hold and mean price target of $9.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and r","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QTTB"],"gpt_icon":0},{"id":"2510880179","title":"Q32 Bio Cut to Neutral From Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2510880179","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510880179?lang=en_us&edition=fundamental","pubTime":"2025-02-11 18:59","pubTimestamp":1739271540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QTTB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2025 05:59 ET (10:59 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB"],"gpt_icon":0},{"id":"2510729806","title":"Q32 Bio downgraded to Neutral from Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2510729806","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510729806?lang=en_us&edition=fundamental","pubTime":"2025-02-11 18:20","pubTimestamp":1739269245,"startTime":"0","endTime":"0","summary":"Piper Sandler downgraded Q32 Bio (QTTB) to Neutral from Overweight with a price target of $4, down from $20. The firm is surprised by the company’s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/q32-bio-downgraded-to-neutral-from-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/q32-bio-downgraded-to-neutral-from-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QTTB"],"gpt_icon":0},{"id":"2510556813","title":"BRIEF-Q32 Bio Inc Restructuring Plan Includes Reduction In Force, Which Co Expects To Substantially Complete By End Of Q2 Of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510556813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510556813?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:39","pubTimestamp":1739223571,"startTime":"0","endTime":"0","summary":"BRIEF-Q32 Bio Inc Restructuring Plan Includes Reduction In Force, Which Co Expects To Substantially Complete By End Of Q2 Of 2025Q32 Bio Inc QTTB.O:Q32 BIO INC: RESTRUCTURING PLAN INCLUDES REDUCTION IN FORCE, WHICH CO EXPECTS TO SUBSTANTIALLY COMPLETE BY END OF Q2 OF 2025Q32 BIO INC: EXPECTS TO INCUR SEVERANCE AND SEVERANCE-RELATED CHARGES OF ABOUT $1.1 MILLIONSource text: [ID:n0000950170-25-017075]Further company coverage: QTTB.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nFWN3P11C4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"gpt_icon":0},{"id":"2510813304","title":"BRIEF-Q32 Bio Inc To Discontinue Renal Basket Trial For Adx-097 To Conserve Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2510813304","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510813304?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:38","pubTimestamp":1739223528,"startTime":"0","endTime":"0","summary":"BRIEF-Q32 Bio Inc To Discontinue Renal Basket Trial For Adx-097 To Conserve ResourcesQ32 Bio Inc QTTB.O:Q32 BIO INC: TO DISCONTINUE RENAL BASKET TRIAL FOR ADX-097 TO CONSERVE RESOURCESQ32 BIO INC: EVA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nFWN3P10R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QTTB"],"gpt_icon":0},{"id":"2510890712","title":"Q32 Bio Inc: Expects to Incur Severance and Severance-Related Charges of About $1.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2510890712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510890712?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:15","pubTimestamp":1739222152,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nFWN3P11C4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"gpt_icon":0},{"id":"2510890209","title":"Q32 Bio Inc: Restructuring Plan Includes Reduction in Force, Which Co Expects to Substantially Complete by End of Q2 of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510890209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510890209?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:15","pubTimestamp":1739222152,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nFWN3P11C4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["QTTB","BK4139"],"gpt_icon":0},{"id":"2510903738","title":"Q32 Bio Inc: Cash Runway Expected to Extend to 2H'26","url":"https://stock-news.laohu8.com/highlight/detail?id=2510903738","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510903738?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:05","pubTimestamp":1739221527,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nFWN3P10R2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"gpt_icon":0},{"id":"2510890390","title":"Q32 Bio Inc:  Initiating Open-Label Extension From Signal-Aa Part a in 1H'25","url":"https://stock-news.laohu8.com/highlight/detail?id=2510890390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510890390?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:05","pubTimestamp":1739221527,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nFWN3P10R2:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"gpt_icon":0},{"id":"2510890324","title":"Q32 Bio Inc: Signal-Aa Part B Remains on Track for Initiation of Dosing in 1H'25, With Topline Data Expected in 1H'26","url":"https://stock-news.laohu8.com/highlight/detail?id=2510890324","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510890324?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:05","pubTimestamp":1739221527,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nFWN3P10R2:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"gpt_icon":0},{"id":"2510536890","title":"Q32 Bio Inc: to Discontinue Renal Basket Trial for Adx-097 to Conserve Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2510536890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510536890?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:05","pubTimestamp":1739221527,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nFWN3P10R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"gpt_icon":0},{"id":"2510314890","title":"Q32 Bio Inc: Evaluate Strategic Options for Its Tissue-Targeted Complement Inhibitor Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2510314890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510314890?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:05","pubTimestamp":1739221527,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nFWN3P10R2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"gpt_icon":0},{"id":"2491353456","title":"BUZZ-Guggenheim downgrades Q32 Bio to 'neutral' as dermatitis drug fails in part of study","url":"https://stock-news.laohu8.com/highlight/detail?id=2491353456","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491353456?lang=en_us&edition=fundamental","pubTime":"2024-12-13 03:05","pubTimestamp":1734030305,"startTime":"0","endTime":"0","summary":"** Guggenheim downgrades drug developer Q32 Bio    to \"neutral\" from \"buy\"   ** Brokerage removes PT; previous PT was $100   ** Co's experimental drug, bempikibart, failed to meet main goal in part of mid-stage trial studying it in patients with atopic dermatitis    ** Co announced trial results after market close on Tuesday, sending shares down ~75% on Wednesday   ** Shares down ~25% at record low of $4.45 on Thursday   ** QTTB plans to move forward with bempikibart for patients with alopecia areata , an autoimmune disease that causes hair loss in patches   ** Co says bempikibart showed improvement in patients with AA in separate trial   ** Brokerage says while signal in AA is encouraging, the trial \"barely worked\" and overall data is significantly below expectations   ** Sees limited hope for applicability of the study for AA based on totality of data   ** Four of seven brokerages rate stock \"buy\" or higher, three \"hold\"; their median PT is $20   ** Including session's moves, stock d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB"],"gpt_icon":0},{"id":"2491577331","title":"Q32 Bio Inc Shares Hit Record Low After Guggenheim Downgrades Stock, Last Down 21.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491577331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491577331?lang=en_us&edition=fundamental","pubTime":"2024-12-13 01:00","pubTimestamp":1734022859,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nFWN3ND0OZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["QTTB","BK4139"],"gpt_icon":0},{"id":"2491377703","title":"Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2491377703","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491377703?lang=en_us&edition=fundamental","pubTime":"2024-12-13 00:00","pubTimestamp":1734019200,"startTime":"0","endTime":"0","summary":"Shares of Q32 Bio QTTB lost nearly 77% yesterday after it reported mixed results from two separate phase IIa studies evaluating its investigational drug bempikibart one in atopic dermatitis  and the other in alopecia areata .While data from the AA study showed promising clinical activity for the drug, the study did not meet its primary endpoint in part B of the eczema study.Based on the above results, management has decided to proceed with developing the drug for AA, but will no longer pursue development in the eczema indication.Following the news, shares of Q32 Bio hit an all-time low of $5.80. The latest announcement did not impress investors, who raised concerns about the drug’s efficacy. Wall Street analysts were also not impressed with the results, one even calling it ‘messy.’。Year to date, Q32 Bio’s shares have lost 45.6% compared with the industry’s 8.7% decline.In the past 60 days, 2024 estimates for Castle Biosciences have improved from a loss of 58 cents per share to earnings","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-q32-bio-stock-160000430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","CTMX","AA","BK4153","CSTL","QTTB","BK4585","BK4139","SPRO","BK4588"],"gpt_icon":0},{"id":"2490380148","title":"Q32 Bio Cut to Neutral From Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2490380148","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490380148?lang=en_us&edition=fundamental","pubTime":"2024-12-12 23:24","pubTimestamp":1734017040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/QTTB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 12, 2024 10:24 ET (15:24 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTTB"],"gpt_icon":0},{"id":"2490680067","title":"Q32 Bio Inc : Bmo Cuts Target Price to $22 From $64","url":"https://stock-news.laohu8.com/highlight/detail?id=2490680067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490680067?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:46","pubTimestamp":1734007572,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nFWN3ND16L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","QTTB"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":72,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QTTB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-11","symbol":"QTTB","fiscalQuarterEnding":"2024/12","expectedEps":-1.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-1.16},{"market":"US","date":"2024-05-09","symbol":"QTTB","fiscalQuarterEnding":"2024/03","expectedEps":-1.42,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-13.15},{"market":"US","date":"2024-03-26","symbol":"QTTB","defaultRemindTime":1711459800000,"type":"split","dateTimestamp":1711425600000,"forFactor":18,"toFactor":1,"ratio":18},{"market":"US","date":"2024-03-13","symbol":"QTTB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710302400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2023-11-14","symbol":"QTTB","fiscalQuarterEnding":"2023/09","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699938000000,"reportTimeType":"post","actualEps":-0.57}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QTTB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QTTB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0,"hold":0.75,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0,"analysts":4,"updateTime":1739332800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QTTB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QTTB","date":"2025-05-01","current":-0.408861,"percent":0.976378,"low":-10.694771,"twenty":-8.94268,"median":-5.209018,"eighty":-0.550941,"high":-0.370531,"avg":-4.785109,"sd":3.633615,"marketCap":19516184},"quantilePoints":[{"date":"2024-04-05","current":-4.597074,"twenty":-4.75645,"median":-4.597074,"eighty":-3.952906,"marketCap":247060524},{"date":"2024-04-12","current":-5.285192,"twenty":-4.79019,"median":-4.726928,"eighty":-4.38975,"marketCap":284042061},{"date":"2024-04-19","current":-5.411717,"twenty":-5.438798,"median":-4.767993,"eighty":-4.57532,"marketCap":290841892},{"date":"2024-04-26","current":-6.268535,"twenty":-5.702502,"median":-5.138689,"eighty":-4.700069,"marketCap":336889870},{"date":"2024-05-03","current":-5.72026,"twenty":-5.938238,"median":-5.411717,"eighty":-4.727594,"marketCap":307423936},{"date":"2024-05-10","current":-5.948893,"twenty":-5.966207,"median":-5.603724,"eighty":-4.749348,"marketCap":319711350},{"date":"2024-05-17","current":-6.881182,"twenty":-6.171755,"median":-5.72026,"eighty":-4.765329,"marketCap":369815368},{"date":"2024-05-24","current":-6.526024,"twenty":-6.419477,"median":-5.852334,"eighty":-4.856783,"marketCap":350728123},{"date":"2024-05-31","current":-7.119566,"twenty":-6.557988,"median":-5.896729,"eighty":-4.946904,"marketCap":326617228},{"date":"2024-06-07","current":-5.417118,"twenty":-6.655355,"median":-5.948893,"eighty":-5.16799,"marketCap":248515704},{"date":"2024-06-14","current":-5.122964,"twenty":-6.625166,"median":-5.89118,"eighty":-5.079231,"marketCap":235021098},{"date":"2024-06-21","current":-4.172821,"twenty":-6.589953,"median":-5.833467,"eighty":-4.901621,"marketCap":191432327},{"date":"2024-06-28","current":-3.969777,"twenty":-6.557988,"median":-5.738018,"eighty":-4.86516,"marketCap":182117467},{"date":"2024-07-05","current":-4.511228,"twenty":-6.526024,"median":-5.680305,"eighty":-4.760002,"marketCap":206957095},{"date":"2024-07-12","current":-5.841429,"twenty":-6.49406,"median":-5.603724,"eighty":-4.798567,"marketCap":267981374},{"date":"2024-07-15","current":-6.825412,"twenty":-6.526024,"median":-5.660327,"eighty":-4.813855,"marketCap":313122622},{"date":"2024-08-02","current":-9.884093,"twenty":-6.542006,"median":-5.670316,"eighty":-4.829142,"marketCap":453442638},{"date":"2024-08-09","current":-7.500596,"twenty":-6.710706,"median":-5.738018,"eighty":-4.87207,"marketCap":427886482},{"date":"2024-08-16","current":-7.75207,"twenty":-6.825412,"median":-5.856316,"eighty":-4.928392,"marketCap":442232352},{"date":"2024-08-23","current":-8.155846,"twenty":-7.24299,"median":-5.902278,"eighty":-4.94491,"marketCap":465266543},{"date":"2024-08-30","current":-8.295371,"twenty":-7.548702,"median":-6.028804,"eighty":-4.98294,"marketCap":473226002},{"date":"2024-09-06","current":-9.684274,"twenty":-7.772364,"median":-6.120922,"eighty":-4.998807,"marketCap":552458796},{"date":"2024-09-13","current":-9.610284,"twenty":-8.191784,"median":-6.244914,"eighty":-5.018839,"marketCap":548237871},{"date":"2024-09-20","current":-9.971779,"twenty":-8.294103,"median":-6.360654,"eighty":-5.041746,"marketCap":568860105},{"date":"2024-09-27","current":-9.599714,"twenty":-8.935493,"median":-6.526024,"eighty":-5.050076,"marketCap":547634882},{"date":"2024-10-04","current":-9.037388,"twenty":-9.107996,"median":-6.621961,"eighty":-5.093809,"marketCap":515555851},{"date":"2024-10-11","current":-9.978122,"twenty":-9.382394,"median":-6.703603,"eighty":-5.220301,"marketCap":569221899},{"date":"2024-10-18","current":-10.49394,"twenty":-9.484712,"median":-6.794175,"eighty":-5.315929,"marketCap":598647777},{"date":"2024-10-25","current":-10.06691,"twenty":-9.672968,"median":-6.825412,"eighty":-5.346971,"marketCap":574287009},{"date":"2024-10-31","current":-9.792089,"twenty":-9.748541,"median":-7.119566,"eighty":-5.360507,"marketCap":558609287},{"date":"2024-11-08","current":-9.443128,"twenty":-9.802236,"median":-7.283651,"eighty":-5.372344,"marketCap":572357443},{"date":"2024-11-15","current":-7.16039,"twenty":-9.789552,"median":-7.500596,"eighty":-5.379633,"marketCap":433998376},{"date":"2024-11-22","current":-5.434099,"twenty":-9.773909,"median":-7.256318,"eighty":-5.396215,"marketCap":329366155},{"date":"2024-11-29","current":-5.407973,"twenty":-9.752346,"median":-7.139978,"eighty":-5.371303,"marketCap":327782663},{"date":"2024-12-06","current":-4.760865,"twenty":-9.734588,"median":-6.825412,"eighty":-5.339276,"marketCap":288560806},{"date":"2024-12-13","current":-0.854102,"twenty":-9.716407,"median":-6.794175,"eighty":-5.114636,"marketCap":51767979},{"date":"2024-12-20","current":-0.671224,"twenty":-9.680505,"median":-6.703603,"eighty":-5.031844,"marketCap":40683541},{"date":"2024-12-27","current":-0.719455,"twenty":-9.66543,"median":-6.637987,"eighty":-4.975898,"marketCap":43606909},{"date":"2025-01-03","current":-0.69333,"twenty":-9.621313,"median":-6.605935,"eighty":-4.929676,"marketCap":42023418},{"date":"2025-01-10","current":-0.657156,"twenty":-9.603942,"median":-6.526024,"eighty":-4.86516,"marketCap":39830892},{"date":"2025-01-17","current":-0.631031,"twenty":-9.545173,"median":-6.362567,"eighty":-4.746844,"marketCap":38247401},{"date":"2025-01-24","current":-0.677253,"twenty":-9.492745,"median":-6.288512,"eighty":-4.6939,"marketCap":41048962},{"date":"2025-01-31","current":-0.655147,"twenty":-9.465263,"median":-6.219701,"eighty":-4.511228,"marketCap":39709085},{"date":"2025-02-07","current":-0.63505,"twenty":-9.453365,"median":-6.05877,"eighty":-3.980076,"marketCap":38491015},{"date":"2025-02-14","current":-0.538587,"twenty":-9.43896,"median":-5.948893,"eighty":-0.813105,"marketCap":32644278},{"date":"2025-02-21","current":-0.488345,"twenty":-9.423405,"median":-5.89118,"eighty":-0.724279,"marketCap":29599103},{"date":"2025-02-28","current":-0.450162,"twenty":-9.384931,"median":-5.843753,"eighty":-0.704182,"marketCap":27284770},{"date":"2025-03-07","current":-0.468249,"twenty":-9.351106,"median":-5.738018,"eighty":-0.689713,"marketCap":28381033},{"date":"2025-03-14","current":-0.470191,"twenty":-9.227225,"median":-5.670316,"eighty":-0.675243,"marketCap":22443611},{"date":"2025-03-21","current":-0.53152,"twenty":-9.18875,"median":-5.509385,"eighty":-0.665195,"marketCap":25371039},{"date":"2025-03-28","current":-0.482968,"twenty":-9.161872,"median":-5.425609,"eighty":-0.655147,"marketCap":23053492},{"date":"2025-04-04","current":-0.408861,"twenty":-9.091808,"median":-5.407973,"eighty":-0.643893,"marketCap":19516184},{"date":"2025-04-11","current":-0.429305,"twenty":-9.050837,"median":-5.380674,"eighty":-0.631433,"marketCap":20491993},{"date":"2025-04-17","current":-0.472746,"twenty":-9.045443,"median":-5.362133,"eighty":-0.622992,"marketCap":22565587},{"date":"2025-04-25","current":-0.472746,"twenty":-9.037388,"median":-5.336421,"eighty":-0.57878,"marketCap":22565587},{"date":"2025-05-01","current":-0.408861,"twenty":-8.94268,"median":-5.209018,"eighty":-0.550941,"marketCap":19516184}],"updateTime":1746240707637}}}